Microbot Medical Inc. received a notice from the Nasdaq Stock Market for failing to meet the exchange's $1 minimum bid price listing requirement.

The Israeli medical device company has until Sept. 18 to regain compliance for continued listing on the Nasdaq Capital Market.

To regain compliance, the closing bid price of the company's securities must reach at least $1 per share for a minimum of 10 consecutive business days.